Question 1

What is the catalog number for MC-Val-Cit-PAB-MMAF?

Accepted Answer

The catalog number for MC-Val-Cit-PAB-MMAF is E7655-1mg.

Question 2

What sizes are available for MC-Val-Cit-PAB-MMAF?

Accepted Answer

MC-Val-Cit-PAB-MMAF is available in the following size(s): 1 mg.

Question 3

Is MC-Val-Cit-PAB-MMAF in stock?

Accepted Answer

MC-Val-Cit-PAB-MMAF is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures MC-Val-Cit-PAB-MMAF?

Accepted Answer

MC-Val-Cit-PAB-MMAF is manufactured by Bimake.

Question 5

What is the estimated delivery time for MC-Val-Cit-PAB-MMAF?

Accepted Answer

Estimated delivery time for MC-Val-Cit-PAB-MMAF is approximately 15 business day(s), depending on your location.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 8

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

MC-Val-Cit-PAB-MMAF

Product Specifications

CAS Number

Synonyms

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

2,5-Dioxo-1-pyrrolidinyl 2-(Ethenylthio)ethyl Carbonate

Dioxoacetildenafil

Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2713), CF488A conjugate, 0.1mg/mL

SCRIBBLE (SCRIB) Human Gene Knockout Kit (CRISPR)

Prohibitin (Mitochondrial Marker) (PHB/3194), CF488A conjugate, 0.1mg/mL

Human OLIG3 activation kit by CRISPRa